KIAA0040: A Potential Drug Target for Blood Clots and Cell Signaling

Target Name: KIAA0040

NCBI ID: G9674

KIAA0040

Other Name(s): KIAA0040 variant 1 | KIAA0040, transcript variant 1 | K0040_HUMAN | Uncharacterized protein KIAA0040

KIAA0040: A Potential Drug Target for Blood Clots and Cell Signaling

KIAA0040 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is Kallikrein-related peptidase 40, and it is a member of the serine proteases family 11.

KIAA0040 is known for its role in the regulation of blood clotting andMatrix-assisted diffusion (MAD) of platelets, which are important factors in blood clot formation. It is also involved in the regulation of cell signaling pathways, including the TGF-β pathway.

KIAA0040 is a potential drug target because of its involvement in the regulation of blood clotting, which is a leading cause of death and disability worldwide. In addition, KIAA0040 is also involved in the regulation of cell signaling pathways, which makes it a potential target for drugs that target signaling pathways related to cancer, neurodegenerative diseases, and other chronic diseases.

Research has shown that KIAA0040 is involved in the regulation of platelet function and plays a role in the formation of blood clots. This protein is expressed in high levels in the brain and is involved in the regulation of blood clotting and MAD of platelets.

In addition, KIAA0040 is also involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

Given its involvement in the regulation of blood clotting and cell signaling pathways, KIAA0040 is a potential drug target for diseases that are characterized by the formation of blood clots or the disruption of cell signaling pathways. This protein is also a good candidate for targeting drugs that target the TGF-β pathway, as TGF-β is involved in the regulation of cell growth, differentiation, and survival.

In conclusion, KIAA0040 is a protein that is expressed in various tissues of the body and is involved in the regulation of blood clotting and cell signaling pathways. Given its potential role in the regulation of blood clots and cell signaling pathways, KIAA0040 is a promising drug target for diseases that are characterized by the formation of blood clots or the disruption of cell signaling pathways. Further research is needed to fully understand the role of KIAA0040 in the regulation of blood clotting and cell signaling pathways, as well as its potential as a drug target.

Protein Name: KIAA0040

The "KIAA0040 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIAA0040 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets